Buy Crypto
Markets
Spot
FuturesBTC
Earn
Event Center
Rewards Hub
More
100%+ PoR
RXRX

Recursion Pharmaceuticals, Inc. (RXRX)

NASDAQ
$2.83
+$0.10
(+3.68%)
Previous Close: ⁦$2.72⁩
Market Closed

Last updated: ⁦2026-11-19 02:28:00⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Recursion Pharmaceuticals, Inc. (RXRX) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $2.83, with a market capitalization of $1.81B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.50 to $5.24. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

$1.81B

$2.79

$3.01

$2.78

$2.72

37.59M

23.60M

--

$5.24

$2.50

--

2026-09-30

Recursion Pharmaceuticals, Inc. (RXRX) Latest Closing Stock Price

Recursion Pharmaceuticals, Inc. (RXRX) last closed at $2.83 as of 2026-11-19 01:00:00, up 3.68% ($0.10) from the previous close of $2.72.

During the latest regular trading session, RXRX traded between $2.78 and $3.01, with a volume of 37.59M shares. The closing price was near the lower end and near the lower end of its 52-week range.

Why Is RXRX Stock Up Today?

RXRX is up 1.41% as of the last close.

Recursion shares are trading higher after the company announced it has aligned with the FDA aligned on the design of a registrational Phase 3 trial for REC-4881 in familial adenomatous polyposis.

Source: Benzinga · Updated

Recursion Pharmaceuticals, Inc. (RXRX) 7-Day Stock Price Change

Over the past seven days, Recursion Pharmaceuticals, Inc. (RXRX) moved from $3.81 to $2.83, representing a decline of 25.76% ($0.98).

The stock traded between $2.50 and $3.87 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 22.02 million shares, up versus the previous seven-day period, indicating higher trading activity.

RXRX 52-Week Price Position

Position in Range: 11.9%

52W Low$2.50
52W High$5.24

RXRX is currently trading at $2.83, placing it 11.9% of the way from its 52-week low of $2.50 to its 52-week high of $5.24. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Recursion Pharmaceuticals, Inc. (RXRX)?

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.

Recursion Pharmaceuticals, Inc. Information

Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees
600
Exchange
NASDAQ
Company Website

RXRX News

Latest news related to Recursion Pharmaceuticals, Inc. and RXRX stock.

  • Massive

    Stock Market Today, Nov. 18: Recursion Pharmaceuticals Rises 4% on FDA Alignment for REC-4881 Phase 3 Design

    Recursion Pharmaceuticals stock rose 4% after reaching FDA alignment on the Phase 3 trial design for REC-4881, its AI-enabled treatment for familial adenomatous polyposis. The FDA accepted polyp excision as part of the primary endpoint, potentially allowing for a shorter, less costly trial. However, the Phase 3 trial won't begin until late 2027, requiring patient investors to wait for actual trial results.

    Read Full Article
  • Benzinga

    Morgan Stanley Maintains Equal-Weight on Recursion Pharmaceuticals, Lowers Price Target to $5.6

    Morgan Stanley analyst Vikram Purohit maintains Recursion Pharmaceuticals (NASDAQ:RXRX) with a Equal-Weight and lowers the price target from $5.9 to $5.6.

    Read Full Article
  • Benzinga

    Recursion Has Aligned With the FDA on Its Registrational Phase 3 Trial of Rec-4881 for Familial Adenomatous Polyposis; Trial on Track to Begin in 2H of 2027

    REC-4881 is among the first AI-enabled programs to advance a registrational Phase 3 trial design for a disease with no approved pharmacologic therapies. Its potential as a first-in-class oral therapy for FAP was

    Read Full Article
  • Massive

    Recursion Announces Alignment with FDA on Registrational Phase 3 Trial Design for REC-4881 in Familial Adenomatous Polyposis

    Recursion announced FDA alignment on the Phase 3 trial design for REC-4881, an investigational oral MEK1/2 inhibitor for familial adenomatous polyposis (FAP). The trial will use a novel composite primary endpoint including excision of adenomas ≥10mm across the GI tract. The Phase 2 TUPELO trial showed a 47% median reduction in polyp burden after 12 weeks, with approximately one-third of patients achieving 65%+ reductions. The Phase 3 trial is expected to enroll ~200 patients and begin in the second half of 2027.

    Read Full Article
  • Benzinga

    JP Morgan Maintains Overweight on Recursion Pharmaceuticals, Lowers Price Target to $7

    JP Morgan analyst Priyanka Grover maintains Recursion Pharmaceuticals (NASDAQ:RXRX) with a Overweight and lowers the price target from $10 to $7.

    Read Full Article

Ways to Trade RXRX at MEXC

RXRX MEXC RealStocks

Own real RXRX shares through MEXC's regulated brokerage partner.


Suitable for long-term holding.

  • Own the actual shares
  • Receive dividends and voting rights
  • Buy fractional shares starting at $1

How to Buy Recursion Pharmaceuticals, Inc. (RXRX) Stock on MEXC

Eligible investors can buy real shares of Recursion Pharmaceuticals, Inc. (RXRX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account
Step 1: Open and Verify Your RealStocks Account
Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.
Step 2: Transfer USDT to Your RealStocks Account
Step 2: Transfer USDT to Your RealStocks Account
Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.
Step 3: Search for RXRX and Place Your Order
Step 3: Search for RXRX and Place Your Order
Open the RealStocks trading page and search for RXRX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Recursion Pharmaceuticals, Inc. (RXRX) stock price today?
Recursion Pharmaceuticals, Inc. (RXRX) is currently trading at $2.83, up 3.68% ($0.10) from the previous close of $2.72. Intraday prices update in real time during regular trading hours.
2.Is RXRX stock going up or down today?
As of 2026-11-19 01:00:00, RXRX is trading at $2.83, up 3.68% ($0.10) from its previous close of $2.72. The stock has traded between $2.78 and $3.01 during today’s regular session. Past price movements do not guarantee future results.
3.What is RXRX pre-market price?
As of 2026-11-19 01:00:00, RXRX is trading at $2.79 in pre-market trading, up 2.72% ($0.07) from the previous close of $2.72. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.
4.What is RXRX after-hours price?
As of 2026-11-19 01:00:00, RXRX is trading at $2.88 in after-hours trading, up 1.88% ($0.05) from the regular-session close of $2.83. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.
5.Is RXRX stock trading now?
RXRX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.
6.Where does RXRX sit relative to its 52-week high and low?
Over the past 52 weeks, RXRX has traded between a low of $2.50 and a high of $5.24. At $2.83, the stock is positioned 11.9% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.
7.What sector is Recursion Pharmaceuticals, Inc. in?
Recursion Pharmaceuticals, Inc. (RXRX) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.
8.What is Recursion Pharmaceuticals, Inc.'s market capitalization and where is it listed?
Recursion Pharmaceuticals, Inc. is listed on the NASDAQ exchange with a market capitalization of $1.81B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.
9.How is RXRX valued in terms of P/E ratio and EPS?
RXRX trades at a P/E ratio of --, based on trailing-twelve-month EPS of $-0.76. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.
10.Does Recursion Pharmaceuticals, Inc. pay a dividend?
Recursion Pharmaceuticals, Inc. pays an indicated annual cash dividend of $0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as Recursion Pharmaceuticals, Inc.

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

Compliance Disclosure and Data Source

Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to RXRX, including Stocks, Tokenized Stocks, and Stock Futures.

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

Search Stocks

RXRX Stock Calculator

Estimate the value between RXRX shares and USD.

RXRX Shares to USD

RXRX Shares
RXRX
RXRX
USD
USD
USD

1.00 RXRX shares = 2.825 USD

Calculations are estimates based on the latest available price and are for reference only.